![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-backs-innovivas-drug-multidrug-resistant-bacterial-infections-2023-04-17/
https://www.globenewswire.com/news-release/2022/06/09/2459626/0/en/Entasis-Therapeutics-Presents-Data-on-Sulbactam-Durlobactam-and-ETX0462-at-2022-ASM-Microbe-Annual-Conference.html
https://finance.yahoo.com/news/entasis-therapeutics-announces-positive-topline-200500307.html